SAN FRANCISCO, Jan 13 (Reuters) - AstraZeneca has agreed to buy Boston-based Modella AI, the companies said on Tuesday, as the drug industry increases its use of artificial intelligence to accelerate the discovery of new drugs.
The companies did not disclose financial terms. In a press release, Modella AI said its "foundation models" and AI agents would be integrated into oncology research and development to support clinical development and biomarker discovery.
"Oncology drug development is becoming more complex, more data-rich and more time-sensitive," said Gabi Raia, Modella AI's chief commercial officer, adding that joining AstraZeneca would allow it to deploy its tools in global trials and clinical settings.
AstraZeneca said that this was the first acquisition of an AI firm by a big pharmaceutical company.
In an interview at the JP Morgan Healthcare Conference, AstraZeneca Chief Financial Officer Aradhana Sarin said the acquisition would "supercharge" the company's quantitative pathology and biomarker discovery efforts by bringing more data and AI capabilities in-house.
The deal was one of a number of pacts between major drug firms and AI companies that were unveiled at the healthcare conference, including a $1 billion collaboration between Nvidia and Eli Lilly. They plan to build a new research lab using Nvidia's latest-generation AI chips.
Modella will accelerate AstraZeneca’s efforts to make pathology more quantitative - using computers to analyze biopsies for relevant proteins and correlate them with clinical data - so AstraZeneca can develop “highly targeted biomarkers and then highly targeted therapeutics,” Sarin said.
The deal is an expansion of a multi-year collaboration that the companies unveiled in July.
Sarin said that partnership served as a "test drive," adding that AstraZeneca ultimately wanted Modella's data, foundation models and AI talent in-house.
She said AI tools could be used to more rapidly select patients for drug trials, which could increase the odds of clinical success and cut related costs.
(Reporting by Maggie Fick; Editing by Thomas Derpinghaus)
LATEST POSTS
- 1
Ten Awesome Authentic Realities That Will Leave You Interested - 2Figure out how to Keep up with Your Dental Inserts for Long haul Achievement
- 3Vote In favor of Your #1 Compelling Female Producer
- 4Live long and loiter: Why NASA's ESCAPADE probes will wait a year in space before heading to Mars
- 5Five held on suspicion of planning attack on German Christmas market
- Vote In favor of Your Number one Game Control center
- Step by step instructions to Explore Assessment Ramifications of Disc Rates
- The Best 15 Applications for Efficiency and Association
- I spent the last year transforming my life. Becoming a Rockette for a day made me confront a fear I couldn't shake.
- Native artists in Texas and Mexico shared their vision of the universe for 4,000 years, ancient murals suggest
- Vote in favor of the bloom plan that adds a bit of excellence to your life!
- Brazil's former President Jair Bolsonaro seeks house arrest for prison time citing health issues
- This Week In Space podcast: Episode 189 — Privatizing Orbit
- Figure out How to Advance Space in Your Pre-assembled Home for Upgraded Usefulness
